#

Heart Failure

  • Compensation to be determined
  • At least 10 visits
#

18+ Years

#
Male or Female
#
Smoker & Non-Smoker

Description

This is a 3-year study testing whether the investigational product can reduce heart failure events and heart failure-related deaths in people who have been recently admitted for heart failure exacerbation, and who have an ejection fraction above 40%.

Is this not what you are looking for?
Check out our other studies.

Related Studies

#

COPD

  • Compensation to be determined
  • 7 study visits
#
Between 40 to 80 years old Years

#
Male or Female
#
Only smokers or ex smokers
#

Heart Failure

  • Compensation to be determined
  • At least 10 visits
#
18+ Years

#
Male or Female
#
Smoker & Non-Smoker
#

Non-alcoholic steatohepatitis (NASH)

  • Compensation to be determined
  • 18 study visits
#
18+ Years

#
Male or Female
#
Smoker & Non-Smoker
© 2025 Access Research Institute. All Rights Reserved